These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 833632)

  • 1. Brain-tumor therapy. Quantitative analysis using a model system.
    Rosenblum MK; Knebel KD; Vasquez DA; Wilson CB
    J Neurosurg; 1977 Feb; 46(2):145-54. PubMed ID: 833632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Rosenblum ML; Wheeler KT; Wilson CB; Barker M; Knebel KD
    Cancer Res; 1975 Jun; 35(6):1387-91. PubMed ID: 1131813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy.
    Rosenblum ML; Knebel KD; Vasquez DA; Wilson CB
    Cancer Res; 1976 Oct; 36(10):3718-25. PubMed ID: 953998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved treatment of a brain-tumor model. Part 2: Sequential therapy with BCNU and 5-fluorouracil.
    Gerosa MA; Dougherty DV; Wilson CB; Rosenblum ML
    J Neurosurg; 1983 Mar; 58(3):368-73. PubMed ID: 6827321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pharmacologic doses of zinc on the therapeutic index of brain tumor chemotherapy with carmustine.
    Roosen N; Doz F; Yeomans KL; Dougherty DV; Rosenblum ML
    Cancer Chemother Pharmacol; 1994; 34(5):385-92. PubMed ID: 7520843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved treatment of a brain-tumor model. Part 1: Advantages of single- over multiple-dose BCNU schedules.
    Rosenblum ML; Gerosa MA; Dougherty DV; Wilson CB
    J Neurosurg; 1983 Feb; 58(2):177-82. PubMed ID: 6848673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model.
    Bullard DE; Bigner SH; Bigner DD
    Cancer Res; 1985 Nov; 45(11 Pt 1):5240-5. PubMed ID: 4053004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of perfluorochemicals on BCNU chemotherapy in a rat brain-tumor model].
    Kokunai T; Kuwamura K
    No To Shinkei; 1982 Jun; 34(6):609-15. PubMed ID: 7115598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined growth-inhibitory responses and ultrastructural alterations produced by 1,3-bis(2-chloroethyl)-1-nitrosourea and dexamethasone in rat glioma cell cultures.
    Grasso RJ; Johnson CE; Boler RK; Moore NA
    Cancer Res; 1977 Feb; 37(2):585-94. PubMed ID: 832280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentials and limitations of a clonogenic cell assay for human brain tumors.
    Rosenblum ML; Dougherty DV; Deen DF; Wilson CB
    Cancer Treat Rep; 1981; 65 Suppl 2():61-6. PubMed ID: 7346148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of surgery on BCNU chemotherapy in a rat brain tumor model.
    Tel E; Hoshino T; Barker M; Wilson CB
    J Neurosurg; 1980 Apr; 52(4):529-32. PubMed ID: 7373376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Sano Y; Hoshino T; Barker M; Deen DF
    Cancer Res; 1984 Feb; 44(2):571-6. PubMed ID: 6692362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.
    Chenevert TL; McKeever PE; Ross BD
    Clin Cancer Res; 1997 Sep; 3(9):1457-66. PubMed ID: 9815831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of difluoromethylornithine on the antiglioma therapeutic efficacy of intra-arterial BCNU.
    Cohen AR; Pietronigro DD; Cravioto H; Flamm ES
    J Neurosurg; 1986 Nov; 65(5):671-8. PubMed ID: 3095505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha-difluoromethylornithine on the growth of 9L rat brain tumor multicellular spheroids and their response to 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Sano Y; Deen DF; Oredsson SM; Marton LJ
    Cancer Res; 1984 Feb; 44(2):577-81. PubMed ID: 6420048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
    Slagel DE; Feola J; Houchens DP; Ovejera AA
    Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
    Zhang RX; Dougherty DV; Rosenblum ML
    Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined cyclotron fast-neutron and BCNU therapy in a rat brain-tumor model.
    Spence AM; Geraci JP
    J Neurosurg; 1981 Apr; 54(4):461-7. PubMed ID: 7205347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea and low dose rate radiation in the 9L rat brain tumor and spheroid models: implications for brain tumor brachytherapy.
    Gutin PH; Bernstein M; Sano Y; Deen DF
    Neurosurgery; 1984 Dec; 15(6):781-6. PubMed ID: 6514150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.